Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79310478 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2021-03-10 | Application Filed |
2021-05-13 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-05-13 | Status: Live/Pending |
2021-05-19 | Transaction Date |
Owner: | ![]() |
Address | 3-5-1, Nihonbashi Honcho, Chuo-ku Tokyo 103-8426 JP |
Legal Entity Type | Corporation |
Legal Entity State | JP |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, metastasis, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-05-13 | 1 REPR M: |
LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2021-05-17 | 2 LIMI I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-05-19 | 3 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2021-05-25 | 4 MAFR O:Outgoing Correspondence |
NEW REPRESENTATIVE AT IB RECEIVED | 2021-06-26 | 5 NREP P: |
ASSIGNED TO EXAMINER | 2021-08-12 | 6 DOCK D:Assigned to Examiner |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-08-17 | 7 CNSA O:Outgoing Correspondence |
NOTICE OF PUBLICATION | 2021-09-01 | 8 NPUB O:Outgoing Correspondence |
PUBLISHED FOR OPPOSITION | 2021-09-21 | 9 PUBO A:Allowance for Publication |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2021-10-13 | 10 ETOF T:TTAB Proceeding |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-12-01 | 11 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-12-01 | 12 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-12-01 | 13 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-12-01 | 14 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-12-01 | 15 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-12-01 | 16 CHAN I:Incoming Correspondence |
TEAS EXPRESS ABANDONMENT RECEIVED | 2021-12-01 | 17 EXAR I:Incoming Correspondence |
ABANDONMENT - AFTER PUBLICATION | 2021-12-06 | 18 ABN5 O:Outgoing Correspondence |
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | 2021-12-07 | 19 MAB5 E:E-Mail |
NEW REPRESENTATIVE AT IB RECEIVED | 2022-07-03 | 20 NREP P: |
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2022-10-19 | 21 OPNR P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2022-10-19 | 22 OPNS P: |
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2022-11-07 | 23 OPNX P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.